Details for Patent: 7,696,159
✉ Email this page to a colleague
Summary for Patent: 7,696,159
Title: | Treatment for basal cell carcinoma |
Abstract: | The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered. |
Inventor(s): | Owens; Mary L. (Cottage Grove, MN), Fox; Terrance L. (Oakdale, MN), Ginkel; Angela M. (St. Paul, MN) |
Assignee: | Graceway Pharmaceuticals, LLC (Bristol, TN) |
Application Number: | 12/008,961 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 7,696,159
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ALDARA | imiquimod | CREAM;TOPICAL | 020723-001 | Feb 27, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |